To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
The Biotechnology Faculty has been created by grouping relevant Sections from other F1000 Faculties, it therefore does not have separate Heads of Faculty, Section Heads or Faculty Members.
The authors describe their follow-up program around a previous antibacterial clinical candidate that failed owing to a cardiovascular safety liability. By improving the physical properties in a very specific part of their lead molecule, they...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
8 Recommendations, most recent by| New Finding | Novel Drug Target
Past 7 Days
New Articles Recommended
Past 30 Days
38Articles Classified As Interesting Hypothesis6,839 total
14Articles Classified As Novel Drug Target3,178 total
21Articles Classified As Confirmation4,561 total
43Articles Classified As Good for Teaching1,756 total
28Articles Classified As Technical Advance11,042 total
5Articles Classified As Controversial1,762 total
128Articles Classified As New Finding25,818 total
3Articles Classified As Refutation281 total
8Articles Classified As Review / Commentary836 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.